Preclinical characterization of JAK1/JAK2 inhibitors for treatment of type 1 diabetes

被引:0
|
作者
Scott, N. A. [1 ,2 ]
Trivedi, P. M. [1 ,2 ]
Graham, K. L. [1 ,2 ]
Fynch, S. [1 ]
Jenkins, M. R. [3 ]
Kay, T. W. [1 ,2 ]
Thomas, H. E. [1 ,2 ]
机构
[1] St Vincents Inst, Immunol & Diabet Unit, Fitzroy, Vic, Australia
[2] Univ Melbourne, St Vincents Hosp, Dept Med, Fitzroy, Vic, Australia
[3] Peter MacCallum Canc Ctr, Canc Immunol Res, East Melbourne, Australia
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
3795
引用
收藏
页码:361 / 361
页数:1
相关论文
共 50 条
  • [41] The discovery of 2,5-isomers of triazole-pyrrolopyrimidine as selective Janus kinase 2 (JAK2) inhibitors versus JAK1 and JAK3
    Lee, Sun-Mi
    Yoon, Kyoung Bin
    Lee, Hyo Jeong
    Kim, Jiwon
    Chung, You Kyoung
    Cho, Won-Jea
    Mukai, Chisato
    Choi, Sun
    Kang, Keon Wook
    Han, Sun-Young
    Ko, Hyojin
    Kim, Yong-Chul
    BIOORGANIC & MEDICINAL CHEMISTRY, 2016, 24 (21) : 5036 - 5046
  • [42] ALTERNATING USE OF DIFFERENT JAK1/JAK2 INHIBITORS, A POSSIBLE THERAPEUTIC STRATEGY USEFUL IN PRIMARY MYELOFIBROSIS: A CASE REPORT
    Gutierrez, Lopez de Ocariz X.
    Vera, Guerrero E.
    Carreno, Gomez-Tarragona G.
    Buendia, Urena B.
    De Nicolas, Sol R.
    Hidalgo, Soto M.
    Lopez, Munoz N.
    Zamanillo, Herreros, I
    Iniguez, Garcia R.
    Poza, Santaella M.
    Ayala, Diaz R.
    Martinez, Lopez J.
    HAEMATOLOGICA, 2020, 105 : 395 - 395
  • [43] Role of JAK1, JAK2, and JAK3 in Functional Stimulation of Mesenchymal Precursor Cells by Alkaloid Songorine
    G. N. Zyuz’kov
    E. V. Udut
    L. A. Miroshnichenko
    E. V. Simanina
    T. Yu. Polyakova
    L. A. Stavrova
    V. V. Udut
    M. Yu. Minakova
    A. M. Dygai
    A. V. Chaikovskii
    V. I. Agafonov
    V. V. Zhdanov
    Bulletin of Experimental Biology and Medicine, 2017, 163 : 443 - 446
  • [44] 2,5-Isomers of triazole-pyrrolopyrimidine act as selective inhibitors of Janus kinase 2 (JAK2) compared to JAK1 and JAK3
    Sun-mi, Lee
    Kim, Yong-Chul
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 252
  • [45] The growth hormone receptor associates with Jak1, Jak2 and Tyk2 in human liver
    Hellgren, G
    Jansson, JO
    Carlsson, LMS
    Carlsson, B
    GROWTH HORMONE & IGF RESEARCH, 1999, 9 (03) : 212 - 218
  • [46] Preclinical characterization of atiprimod, a novel JAK2 AND JAK3 inhibitor
    Alfonso Quintás-Cardama
    Taghi Manshouri
    Zeev Estrov
    David Harris
    Ying Zhang
    Amos Gaikwad
    Hagop M. Kantarjian
    Srdan Verstovsek
    Investigational New Drugs, 2011, 29 : 818 - 826
  • [47] Discovery and Optimization of C-2 Methyl Imidazopyrrolopyridines as Potent and Orally Bioavailable JAK1 Inhibitors with Selectivity over JAK2
    Zak, Mark
    Mendonca, Rohan
    Balazs, Mercedesz
    Barrett, Kathy
    Bergeron, Philippe
    Blair, Wade S.
    Chang, Christine
    Deshmukh, Gauri
    DeVoss, Jason
    Dragovich, Peter S.
    Eigenbrot, Charles
    Ghilardi, Nico
    Gibbons, Paul
    Gradl, Stefan
    Hamman, Chris
    Hanan, Emily J.
    Harstad, Eric
    Hewitt, Peter R.
    Hurley, Christopher A.
    Jin, Tian
    Johnson, Adam
    Johnson, Tony
    Kenny, Jane R.
    Koehler, Michael F. T.
    Kohli, Pawan Bir
    Kulagowski, Janusz J.
    Labadie, Sharada
    Liao, Jiangpeng
    Liimatta, Marya
    Lin, Zhonghua
    Lupardus, Patrick J.
    Maxey, Robert J.
    Murray, Jeremy M.
    Pulk, Rebecca
    Rodriguez, Madeleine
    Savage, Scott
    Shia, Steven
    Steffek, Micah
    Ubhayakar, Savita
    Ultsch, Mark
    van Abbema, Anne
    Ward, Stuart I.
    Xiao, Ling
    Xiao, Yisong
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (13) : 6176 - 6193
  • [48] Preclinical characterization of atiprimod, a novel JAK2 AND JAK3 inhibitor
    Quintas-Cardama, Alfonso
    Manshouri, Taghi
    Estrov, Zeev
    Harris, David
    Zhang, Ying
    Gaikwad, Amos
    Kantarjian, Hagop M.
    Verstovsek, Srdan
    INVESTIGATIONAL NEW DRUGS, 2011, 29 (05) : 818 - 826
  • [49] Role of JAK1, JAK2, and JAK3 in Functional Stimulation of Mesenchymal Precursor Cells by Alkaloid Songorine
    Zyuz'kov, G. N.
    Udut, E. V.
    Miroshnichenko, L. A.
    Simanina, E. V.
    Polyakova, T. Yu.
    Stavrova, L. A.
    Udut, V. V.
    Minakova, M. Yu.
    Dygai, A. M.
    Chaikovskii, A. V.
    Agafonov, V. I.
    Zhdanov, V. V.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2017, 163 (04) : 443 - 446
  • [50] JAK2 inhibitors
    Hernandez Boluda, Juan Carlos
    Gomez, Montse
    Perez, Ariadna
    MEDICINA CLINICA, 2016, 147 (02): : 70 - 75